These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34707682)

  • 1. Optimal Allocation of Vaccine and Antiviral Drugs for Influenza Containment over Delayed Multiscale Epidemic Model considering Time-Dependent Transmission Rate.
    Abbasi Z; Zamani I; Amiri Mehra AH; Ibeas A; Shafieirad M
    Comput Math Methods Med; 2021; 2021():4348910. PubMed ID: 34707682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal control and sensitivity analysis of an influenza model with treatment and vaccination.
    Tchuenche JM; Khamis SA; Agusto FB; Mpeshe SC
    Acta Biotheor; 2011 Mar; 59(1):1-28. PubMed ID: 20140696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal control of vaccination dynamics during an influenza epidemic.
    Jaberi-Douraki M; Moghadas SM
    Math Biosci Eng; 2014 Oct; 11(5):1045-63. PubMed ID: 25347806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A note on the use of optimal control on a discrete time model of influenza dynamics.
    González-Parra PA; Lee S; Velázquez L; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):183-97. PubMed ID: 21361407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observer-based adaptive PI sliding mode control of developed uncertain SEIAR influenza epidemic model considering dynamic population.
    Mehra AHA; Zamani I; Abbasi Z; Ibeas A
    J Theor Biol; 2019 Dec; 482():109984. PubMed ID: 31449819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized strategy for the control and prevention of newly emerging influenza revealed by the spread dynamics model.
    Zhang WD; Zu ZH; Xu Q; Xu ZJ; Liu JJ; Zheng T
    PLoS One; 2014; 9(1):e84694. PubMed ID: 24392151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for influenza with vaccination and antiviral treatment.
    Arino J; Brauer F; van den Driessche P; Watmough J; Wu J
    J Theor Biol; 2008 Jul; 253(1):118-30. PubMed ID: 18402981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Optimal Control to Influenza Pneumonia Coinfection with Antiviral Resistance.
    Kanyiri CW; Luboobi L; Kimathi M
    Comput Math Methods Med; 2020; 2020():5984095. PubMed ID: 32256682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the effects of vaccination and treatment on pandemic influenza.
    Feng Z; Towers S; Yang Y
    AAPS J; 2011 Sep; 13(3):427-37. PubMed ID: 21656080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Transmission Precautions Best Control Influenza Spread in a Hospital?
    Blanco N; Eisenberg MC; Stillwell T; Foxman B
    Am J Epidemiol; 2016 Jun; 183(11):1045-54. PubMed ID: 27188950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing vaccine allocation at different points in time during an epidemic.
    Matrajt L; Longini IM
    PLoS One; 2010 Nov; 5(11):e13767. PubMed ID: 21085686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-interest versus group-interest in antiviral control.
    van Boven M; Klinkenberg D; Pen I; Weissing FJ; Heesterbeek H
    PLoS One; 2008; 3(2):e1558. PubMed ID: 19050769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal control of vertically transmitted disease: an integrated approach.
    Bhattacharyya S; Ghosh S
    Comput Math Methods Med; 2010 Dec; 11(4):369-87. PubMed ID: 21058080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can treatment increase the epidemic size?
    Xiao Y; Brauer F; Moghadas SM
    J Math Biol; 2016 Jan; 72(1-2):343-61. PubMed ID: 25925242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical model of transmission dynamics and optimal control strategies for 2009 A/H1N1 influenza in the Republic of Korea.
    Kim S; Lee J; Jung E
    J Theor Biol; 2017 Jan; 412():74-85. PubMed ID: 27769686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission dynamics of an influenza model with vaccination and antiviral treatment.
    Qiu Z; Feng Z
    Bull Math Biol; 2010 Jan; 72(1):1-33. PubMed ID: 19568726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Bartsch SM; Taitel MS; DePasse JV; Cox SN; Smith-Ray RL; Wedlock P; Singh TG; Carr S; Siegmund SS; Lee BY
    Vaccine; 2018 Nov; 36(46):7054-7063. PubMed ID: 30340884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal H1N1 vaccination strategies based on self-interest versus group interest.
    Shim E; Meyers LA; Galvani AP
    BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S4. PubMed ID: 21356133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.